Literature DB >> 2005150

Primary total knee arthroplasty in patients with psoriasis.

C A Beyer1, A D Hanssen, D G Lewallen, M R Pittelkow.   

Abstract

Between 1976 and 1988, 50 primary total knee arthroplasties were performed on 34 patients with psoriasis vulgaris. The skin lesions were graded for severity in all patients and the extent of affected body surface was mapped. All patients received peri-operative antibiotics. Only one deep infection, with Staphylococcus aureus, occurred 25 months after operation. The average length of follow-up was nearly four and a half years, being to a minimum of two years or until failure of the arthroplasty. There appears to be no increased risk of deep infection in patient with psoriasis vulgaris undergoing primary total knee arthroplasty.

Entities:  

Mesh:

Year:  1991        PMID: 2005150

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

1.  Psoriasis is a risk factor for hip-prosthesis infection.

Authors:  M Drancourt; J N Argenson; H Tissot Dupont; J M Aubaniac; D Raoult
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

2.  Wound healing in a patient with psoriasis vulgaris and femur megaprosthesis implantation.

Authors:  Markus Nottrott; Jendrik Hardes; Winfried Winkelmann; Georg Gosheger
Journal:  Sarcoma       Date:  2008

Review 3.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

4.  India Joining the World of Hip and Knee Registries: Present Status-A Leap Forward.

Authors:  Shrinand V Vaidya; Abhinav D Jogani; Jahavir A Pachore; Richard Armstrong; Chintan S Vaidya
Journal:  Indian J Orthop       Date:  2020-09-16       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.